Publications by authors named "Jai Purohit"
Article Synopsis
- The study examines the clinical utility and economic implications of pharmacogenetic testing (PGT) for warfarin therapy in low to middle-income countries, comparing it to standard care (SOC).
- It involved a randomized trial with 168 patients and found that those receiving PGT-guided therapy spent significantly more time in the therapeutic INR range and reached this range faster than those on SOC.
- Despite the slightly higher lifetime costs for PGT therapy, the quality-adjusted life years (QALY) gained were similar for both treatment strategies, suggesting that cost-effective benefits may exist with PGT in specific scenarios.
